Sustained Remission After Treatment Withdrawal in Autoimmune Hepatitis: A Multicenter Retrospective Study
Author(s) -
Yasmina Ben Merabet,
Coralie Barbe,
Alexandra Heurgué–Berlot,
Thierry Thévenot,
Anne Minello,
François Habersetzer,
Didier Samuel,
Brigitte BernardChabert,
Delphine Weil,
Pascal Renard,
Hélène Clot,
Vincent Di Martino,
Hervé Louvet,
Solange BressonHadni,
Gérard Thiéfin
Publication year - 2020
Publication title -
digestive diseases and sciences
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.14
H-Index - 124
eISSN - 1573-2568
pISSN - 0163-2116
DOI - 10.1007/s10620-020-06444-7
Subject(s) - medicine , gastroenterology , autoimmune hepatitis , liver biopsy , fibrosis , hepatology , biopsy , retrospective cohort study , hepatitis
In patients with autoimmune hepatitis (AIH), relapse rates between 25 and 100% after treatment withdrawal have been reported. The optimal strategy for immunosuppressive treatment withdrawal is controversial.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom